When is Serevent Diskus recommended for use?

When is Serevent Diskus recommended for use?

• A. As a standalone treatment for acute asthma
• B. In combination with ICS for maintenance
• C. As a sole therapy for exercise-induced asthma
• D. For immediate relief of asthma symptoms

Answer: (B)

Serevent Diskus, which contains the long-acting beta-agonist (LABA) salmeterol, is specifically indicated for use in combination with inhaled corticosteroids (ICS) as a maintenance treatment for asthma. This is because LABAs are not effective as standalone therapy for acute asthma attacks or for immediate relief of symptoms, as they take longer to act compared to short-acting beta-agonists. When combined with ICS, Serevent helps to maintain control of asthma symptoms by reducing airway inflammation and preventing bronchospasm, thus improving overall respiratory function. This combination is crucial for patients who require a long-term management strategy for chronic asthma maintenance, rather than managing acute episodes.

Serevent Diskus, which contains the long-acting beta-agonist (LABA) salmeterol, is specifically indicated for use in combination with inhaled corticosteroids (ICS) as a maintenance treatment for asthma. This is because LABAs are not effective as standalone therapy for acute asthma attacks or for immediate relief of symptoms, as they take longer to act compared to short-acting beta-agonists. When combined with ICS, Serevent helps to maintain control of asthma symptoms by reducing airway inflammation and preventing bronchospasm, thus improving overall respiratory function. This combination is crucial for patients who require a long-term management strategy for chronic asthma maintenance, rather than managing acute episodes.